US equities |
TSLA $393.72 ▲+5.78% MU $910.71 ▲+3.78% NVDA $216.35 ▲+2.56% SPCX $148.06 ▲+0.39% META $632.85 ▼-1.52% AAPL $344.25 ▼-1.00% SNDK $1,263.50 ▲+2.06% INTC $91.41 ▲+5.12%
FinancialContent

Apnimed, Inc. - Common Stock (NQ:APMD)

18.65 -0.34 (-1.79%)
Delayed Quote Updated: 3:34 PM EDT, Oct 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Apnimed, Inc. - Common Stock

News headline image
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
CHEST-led panel to showcase data from the Phase 3 SynAIRgy and LunAIRo trials, exploring potential new paradigms for advancing OSA patient management 
From Apnimed, Inc.
Via GlobeNewswire
News headline image
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Apnimed, Inc.
Via GlobeNewswire
News headline image
Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update
From Apnimed, Inc.
Via GlobeNewswire
News headline image
Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Apnimed, Inc.
Via GlobeNewswire